What’s Exciting About Bimatoprost SR Glaucoma Drug Implant

Video Transcript: One of the challenges of treating glaucoma is that for most people, it’s a condition without notable symptoms. What this means is that the treatment is often more bothersome than the condition itself (at least early on in the disease). Take for...

PolyActiva Commences Clinical Trial of Biodegradable Ocular Implant for Glaucoma

Clinical Trial Begins For PolyActiva Biodegradable Glaucoma Implant. PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently received USD$12million in venture capital to fund its Phase 1 Clinical Trial which will evaluate the safety and tolerability of its PA5108 ocular implant designed to biodegrade after the treatment period.

Could a New Class of Glaucoma Medications Be Around The Corner?

An exciting new class of potential glaucoma medications include what are termed the ROCK and ROCK/NET inhibitors. And it’s about time! Twenty years have passed since the last new class of medications (prostaglandin analogs) were approved for the treatment of glaucoma.

Pin It on Pinterest

SiteLock